Amylin announces results from SYMLIN clinical research on type 2 or 1 diabetes Amylin Pharmaceuticals, Inc. Two abstracts highlighting the analyses evaluated the proportion of readings from self-monitored seven-stage glucose profiles that fell above, below or within glycemic targets predicated on guidelines set by the American Diabetes Association and American Association of Clinical Endocrinologists quality read more . The info analyses are being presented at the 72nd Scientific Periods of the ADA in Philadelphia.

Amyloid plaques in regular older individuals could be early signs of Alzheimer’s Potential to identify at-risk individuals may open up the entranceway for preventive therapiesResearchers using two brain-imaging technologies have discovered that apparently normal older people with brain deposits of amyloid beta – the principal constituent of the plaques within the brains of Alzheimer’s disease patients – also had changes in brain structure identical to those observed in Alzheimer’s patients. Results of the scholarly study, which includes received early online publication in the Annals of Neurology, can help identify individuals who could be candidates for therapies to prevent the development of dementia.